Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.

Emminger W, Hernández MD, Cardona V, Smeenk F, Fogh BS, Calderon MA, de Blay F, Backer V.

Int Arch Allergy Immunol. 2017;174(1):35-44. doi: 10.1159/000478699. Epub 2017 Sep 27.

2.

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.

Brunner HI, Ruperto N, Tzaribachev N, Horneff G, Chasnyk VG, Panaviene V, Abud-Mendoza C, Reiff A, Alexeeva E, Rubio-Pérez N, Keltsev V, Kingsbury DJ, Del Rocio Maldonado Velázquez M, Nikishina I, Silverman ED, Joos R, Smolewska E, Bandeira M, Minden K, van Royen-Kerkhof A, Emminger W, Foeldvari I, Lauwerys BR, Sztajnbok F, Gilmer KE, Xu Z, Leu JH, Kim L, Lamberth SL, Loza MJ, Lovell DJ, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).

Ann Rheum Dis. 2018 Jan;77(1):21-29. doi: 10.1136/annrheumdis-2016-210456. Epub 2017 May 15.

3.

Bilateral Infiltrative Dacryoadenitis and Granulomatous Pneumonia in an 11-Year-Old Boy: A Case Report.

Diesner SC, Lukas J, Stifter E, Raimann A, Nachbaur E, Eiwegger T, Renner S, Emminger W, Geleff S, Szepfalusi Z.

Klin Padiatr. 2017 Mar;229(2):96-99. doi: 10.1055/s-0043-100381. Epub 2017 Apr 25. No abstract available.

PMID:
28444655
4.

The quantity and quality of α-gal-specific antibodies differ in individuals with and without delayed red meat allergy.

Kollmann D, Nagl B, Ebner C, Emminger W, Wöhrl S, Kitzmüller C, Vrtala S, Mangold A, Ankersmit HJ, Bohle B.

Allergy. 2017 Feb;72(2):266-273. doi: 10.1111/all.12948. Epub 2016 Jul 15.

5.

Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.

Demoly P, Emminger W, Rehm D, Backer V, Tommerup L, Kleine-Tebbe J.

J Allergy Clin Immunol. 2016 Feb;137(2):444-451.e8. doi: 10.1016/j.jaci.2015.06.036. Epub 2015 Aug 17.

6.

B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ.

Salzer E, Santos-Valente E, Klaver S, Ban SA, Emminger W, Prengemann NK, Garncarz W, Müllauer L, Kain R, Boztug H, Heitger A, Arbeiter K, Eitelberger F, Seidel MG, Holter W, Pollak A, Pickl WF, Förster-Waldl E, Boztug K.

Blood. 2013 Apr 18;121(16):3112-6. doi: 10.1182/blood-2012-10-460741. Epub 2013 Jan 14.

7.

Uveitis- a rare disease often associated with systemic diseases and infections- a systematic review of 2619 patients.

Barisani-Asenbauer T, Maca SM, Mejdoubi L, Emminger W, Machold K, Auer H.

Orphanet J Rare Dis. 2012 Aug 29;7:57. doi: 10.1186/1750-1172-7-57. Review.

8.

SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial.

Durham SR, Emminger W, Kapp A, de Monchy JG, Rak S, Scadding GK, Wurtzen PA, Andersen JS, Tholstrup B, Riis B, Dahl R.

J Allergy Clin Immunol. 2012 Mar;129(3):717-725.e5. doi: 10.1016/j.jaci.2011.12.973. Epub 2012 Jan 29.

9.

Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.

Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W.

Clin Ther. 2011 Jul;33(7):828-40. doi: 10.1016/j.clinthera.2011.06.006. Epub 2011 Jul 7.

PMID:
21741092
10.

Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet.

Durham SR, Emminger W, Kapp A, Colombo G, de Monchy JG, Rak S, Scadding GK, Andersen JS, Riis B, Dahl R.

J Allergy Clin Immunol. 2010 Jan;125(1):131-8.e1-7. doi: 10.1016/j.jaci.2009.10.035.

PMID:
20109743
11.

[Allergen-specific Immunotherapy for children and adolescents - a review on available products in Austria].

Szépfalusi Z, Emminger W, Eitelberger F, Götz M, Grillenberger A, Horak E, Huttegger I, Koller D, Litscher H, Schmitzberger R, Varga EM, Riedler J; Osterreichische Gesellschaft für Kinder und Jugendheilkunde.

Wien Klin Wochenschr. 2009;121(19-20):648-60. doi: 10.1007/s00508-009-1258-8. Review. German.

PMID:
19921133
12.

Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life.

Frølund L, Durham SR, Calderon M, Emminger W, Andersen JS, Rask P, Dahl R.

Allergy. 2010 Jun 1;65(6):753-7. doi: 10.1111/j.1398-9995.2009.02238.x. Epub 2009 Nov 2.

PMID:
19886920
13.

Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years.

Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Riis B, Grønager PM, Durham SR.

J Allergy Clin Immunol. 2008 Feb;121(2):512-518.e2. Epub 2007 Dec 26.

14.

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.

Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR.

J Allergy Clin Immunol. 2006 Aug;118(2):434-40.

PMID:
16890769
15.

A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.

Ruperto N, Nikishina I, Pachanov ED, Shachbazian Y, Prieur AM, Mouy R, Joos R, Zulian F, Schwarz R, Artamonova V, Emminger W, Bandeira M, Buoncompagni A, Foeldvari I, Falcini F, Baildam E, Kone-Paut I, Alessio M, Gerloni V, Lenhardt A, Martini A, Hanft G, Sigmund R, Simianer S; Pediatric Rheumatology International Trials Organization.

Arthritis Rheum. 2005 Feb;52(2):563-72.

16.

Acute hemorrhagic respiratory failure caused by Wegener's granulomatosis successfully treated by bronchoalveolar lavage with diluted surfactant.

Hermon MM, Golej J, Emminger W, Puig S, Szepfalusi Z, Trittenwein G.

Wien Klin Wochenschr. 2003 Nov 28;115(21-22):793-6.

PMID:
14743584
17.

CD14(dim)/CD16(bright) monocytes in hemophagocytic lymphohistiocytosis.

Emminger W, Zlabinger GJ, Fritsch G, Urbanek R.

Eur J Immunol. 2001 Jun;31(6):1716-9.

18.

Organ toxicity and quality of life after allogeneic bone marrow transplantation in pediatric patients: a single centre retrospective analysis.

Matthes-Martin S, Lamche M, Ladenstein R, Emminger W, Felsberger C, Topf R, Gadner H, Peters C.

Bone Marrow Transplant. 1999 May;23(10):1049-53.

19.

Skin-associated lymphocytes in the peripheral blood of patients with atopic dermatitis: signs of subset expansion and stimulation.

Dworzak MN, Fröschl G, Printz D, Fleischer C, Pötschger U, Fritsch G, Gadner H, Emminger W.

J Allergy Clin Immunol. 1999 May;103(5 Pt 1):901-6.

PMID:
10329826
20.

Kinking and stenosis of the carotid artery associated with homolateral ischaemic brain infarction in a patient treated with cyclosporin A.

Huemer M, Emminger W, Trattnig S, Freilinger M, Wandl-Vergesslich K.

Eur J Pediatr. 1998 Jul;157(7):599-601.

PMID:
9686825
21.
22.

First experience with prognostic factors in unselected neuroblastoma patients. The Austrian Neuroblastoma 87 Study.

Ladenstein R, Urban C, Gadner H, Fink FM, Zoubek A, Emminger W, Grienberger H, Schmitt K, Ambros PF, Ambros IM, et al.

Eur J Cancer. 1995;31A(4):637-41.

PMID:
7576985
23.

Stem cell procurement and transplantation in paediatric patients.

Höcker P, Emminger W, Peters C.

Transfus Sci. 1994 Dec;15(4):339-42.

PMID:
10155551
24.

Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation.

Födinger M, Fritsch G, Winkler K, Emminger W, Mitterbauer G, Gadner H, Valent P, Mannhalter C.

Blood. 1994 Nov 1;84(9):2954-9.

25.

High-dose cyclophosphamide, adriamycin, and vincristine (HD-CAV) in children with recurrent solid tumor.

Zoubek A, Holzinger B, Mann G, Peters C, Emminger W, Perneczky-Hintringer E, Gadner H, Mostbeck G, Horcher E, Dobrowsky W.

Pediatr Hematol Oncol. 1994 Nov-Dec;11(6):613-23.

PMID:
7857784
26.

Influence of fractionated total body irradiation on mucosal toxicity in intensified conditioning regimens for autologous bone marrow transplantation in pediatric cancer patients.

Borgmann A, Emminger W, Emminger-Schmidmeier W, Peters C, Gatterer-Menz I, Henze G, Gadner H.

Klin Padiatr. 1994 Jul-Aug;206(4):299-302.

PMID:
7967427
27.

Tolerance of high doses of amphotericin B by infusion of a liposomal formulation in children with cancer.

Emminger W, Graninger W, Emminger-Schmidmeier W, Zoubek A, Pillwein K, Susani M, Wasserer A, Gadner H.

Ann Hematol. 1994 Jan;68(1):27-31.

PMID:
8110875
28.

Early prednisone treatment and nephropathy in anaphylactoid purpura.

Temmel AF, Emminger W, Schroth B, Zaunschirm HA, Gadner H.

Eur J Pediatr. 1993 Sep;152(9):782-3. No abstract available.

PMID:
8223819
29.

Complete remission of 4 years following autologous blood stem cell transplantation in a child with early relapse of translocation t(9;X) acute lymphoblastic leukemia.

Emminger W, Emminger-Schmidmeier W, Haas OA, Höcker P, Hawliczek R, Peters C, Gadner H.

Pediatr Hematol Oncol. 1992 Jul-Sep;9(3):273-5. No abstract available.

PMID:
1356005
30.

Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.

Emminger W, Emminger-Schmidmeier W, Haas OA, Urban C, Ambros P, Peters C, Mann G, Fink FM, Ferstl G, Höcker P, et al.

Bone Marrow Transplant. 1992 May;9(5):313-8.

PMID:
1617314
31.

Conventional vs. liposomal amphotericin B in immunosuppressed children.

Zoubek A, Emminger W, Emminger-Schmidmeier W, Peters C, Pracher E, Grois N, Gadner H.

Pediatr Hematol Oncol. 1992 Apr-Jun;9(2):187-90.

PMID:
1524992
32.

High-dose melphalan, etoposide, and carboplatin (MEC) +/- fractionated total body irradiation for treatment of advanced solid tumors.

Gadner H, Emminger W, Ladenstein R, Peters C.

Pediatr Hematol Oncol. 1992 Apr-Jun;9(2):v-viii. No abstract available.

PMID:
1524986
33.

Recovery kinetics after chemotherapy and circulating mononuclear cells expressing the CD34 antigen in pediatric cancer patients.

Emminger W, Fritsch G, Emminger-Schmidmeier W, Buchinger P, Printz D, Kundi M, Gadner H.

Ann Hematol. 1992 Apr;64(4):181-4.

PMID:
1374649
35.

Limited tolerance of intensified conditioning regimens in children receiving methotrexate/cyclosporin A for graft-versus-host disease prophylaxis.

Emminger W, Emminger-Schmidmeier W, Peters C, Hawliczek R, Höcker P, Gadner H.

Pediatr Hematol Oncol. 1992 Jan-Mar;9(1):1-9.

PMID:
1558771
36.

[Liposomal amphotericin B in the treatment of candida infection in a 3-month-old infant].

Emminger W, Innerhofer A, Helfert A, Kummer M, Gadner H.

Padiatr Padol. 1992;27(4):97-9. German.

PMID:
1408291
37.

[Veno-occlusive disease of the liver as a treatment complication in children with Wilm's tumor].

Zoubek A, Wiesbauer P, Pracher E, Martins da Cunha AC, Emminger W, Grois N, Gadner H.

Padiatr Padol. 1992;27(2):47-50. German.

PMID:
1318536
38.

CD34 analysis in peripheral blood correlates with colony forming capacity--an update.

Fritsch G, Emminger W, Buchinger P, Printz D, Gadner H.

Prog Clin Biol Res. 1992;377:531-6. No abstract available.

PMID:
1279721
39.

CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity.

Fritsch G, Emminger W, Buchinger P, Printz D, Gadner H.

Exp Hematol. 1991 Dec;19(11):1079-83.

PMID:
1721590
40.

Unusually long survival after autografting in second partial remission of translocation t(4;11) acute infant leukemia.

Emminger W, Emminger-Schmidmeier W, Ambros P, Haas OA, Höcker P, Köller U, Gadner H.

Bone Marrow Transplant. 1991 Oct;8(4):311-3.

PMID:
1756329
41.

Is treatment intensification by adding etoposide and carboplatin to fractionated total body irradiation and melphalan acceptable in children with solid tumors with respect to toxicity?

Emminger W, Emminger-Schmidmeier W, Peters C, Hawliczek R, Höcker P, Gadner H.

Bone Marrow Transplant. 1991 Aug;8(2):119-23.

PMID:
1933052
42.

Influence of immunosuppression on acute liver toxicity after intensified conditioning regimens for bone marrow transplantation in children.

Emminger W, Emminger-Schmidmeier W, Peters C, Gadner H.

Blood. 1991 Apr 1;77(7):1621. No abstract available.

43.

Amphotericin B serum levels in pediatric bone marrow transplant recipients.

Emminger W, Lang HR, Emminger-Schmidmeier W, Peters C, Gadner H.

Bone Marrow Transplant. 1991 Feb;7(2):95-9.

PMID:
2049564
44.

High-dose melphalan, etoposide +/- carboplatin (MEC) combined with 12-gray fractionated total-body irradiation in children with generalized solid tumors.

Emminger W, Emminger-Schmidmeier W, Hawliczek R, Peters C, Höcker P, Gadner H.

Pediatr Hematol Oncol. 1991 Jan-Mar;8(1):13-22.

PMID:
2029464
45.

[Therapy of urinary tract infection].

Graninger W, Presterl E, Radosztics S, Thalhammer F, Emminger W.

Wien Med Wochenschr. 1991;141(23-24):544-51. Review. German.

PMID:
1810094
46.

[Autologous bone marrow transplantation in children with acute leukemia or non-Hodgkin's lymphoma].

Emminger W, Hinterberger W, Emminger-Schmidmeier W, Peters C, Fink FM, Zoubek A, Haas OA, Höcker P, Hawliczek R, Knapp W, et al.

Wien Med Wochenschr. 1991;141(9-10):225-8. German.

PMID:
1683071
47.

Capillary leak syndrome during low dose granulocyte-macrophage colony-stimulating factor (rh GM-CSF) treatment of a patient in a continuous febrile state.

Emminger W, Emminger-Schmidmeier W, Peters C, Susani M, Hawliczek R, Höcker P, Gadner H.

Blut. 1990 Oct;61(4):219-21.

PMID:
2224143
48.

The median daily increment of leukocytes during hematopoietic recovery reflects the myeloid progenitor cell yield during leukapheresis in children.

Emminger W, Emminger-Schmidmeier W, Höcker P, Gerhartl C, Kundi M, Gadner H.

Bone Marrow Transplant. 1990 Jun;5(6):419-24.

PMID:
2369682
49.

Autologous rescue with blood-derived stem cells in a child with non-Hodgkin's lymphoma.

Emminger W, Emminger-Schmidmeier W, Ambros P, Gadner H, Höcker P, Radaszkiewicz T, Hinterberger W.

Pediatr Hematol Oncol. 1990;7(2):137-44.

PMID:
1976380
50.

The median rise of leucocytes predicts the optimal days for leukapheresis in children.

Emminger W, Emminger-Schmidmeier W, Höcker P, Kundi M, Peters C, Gadner H.

Bone Marrow Transplant. 1990 Jan;5 Suppl 1:28-9.

PMID:
1969304

Supplemental Content

Loading ...
Support Center